Flamingo Therapeutics NV
1 clinical trials · Sponsor
◉ Watch Flamingo Therapeutics NV
| Record | Firm | Date |
|---|---|---|
| Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC (NCT05814666) | Flamingo Therapeutics NV | 2023-05-30 |
Track Flamingo Therapeutics NV automatically
Every clearance here is in the API, with alerts when new ones post.